GSTC (GlobeStar Therapeutics) FCF Yield %: 0.00 (As of Jun. 26, 2026)


What is GlobeStar Therapeutics FCF Yield %?

GlobeStar Therapeutics GSTC -99.00% FCF Yield % is 0.00 as of Jun. 26, 2026.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, GlobeStar Therapeutics's Trailing 12-Month Free Cash Flow is $-0.15 Mil, and Market Cap is $0.00 Mil. Therefore, GlobeStar Therapeutics's FCF Yield % for today is 0.00%.

The historical rank and industry rank for GlobeStar Therapeutics's FCF Yield % or its related term are showing as below:


During the past 13 years, the highest FCF Yield % of GlobeStar Therapeutics was 52600.00%. The lowest was -3580900.00%. And the median was 0.00%.

GSTC's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -9.715
* Ranked among companies with meaningful FCF Yield % only.

GlobeStar Therapeutics's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.


GlobeStar Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


GlobeStar Therapeutics FCF Yield % Related Terms


GlobeStar Therapeutics FCF Yield % Historical Data

* Premium members only.

The historical data trend for GlobeStar Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlobeStar Therapeutics FCF Yield % Chart

GlobeStar Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.85 -8.16 -4.52 -12.24 -11.49

GlobeStar Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.08 -16.29 -18.21 -4.59 -6.45

GSTC vs GBLX, ENDV, CNBX: FCF Yield % Comparison

For the Biotechnology subindustry, GlobeStar Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlobeStar Therapeutics FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GlobeStar Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where GlobeStar Therapeutics's FCF Yield % falls into.



GlobeStar Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

GlobeStar Therapeutics's FCF Yield % for the fiscal year that ended in Sep. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.206 / 1.793016
=-11.49%

GlobeStar Therapeutics's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.02 * 4 / 1.241106
=-6.45%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.00 mean?
GlobeStar Therapeutics (GSTC) has a FCF Yield % of 0.00 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on GlobeStar Therapeutics and its competitors.
Is GlobeStar Therapeutics' FCF Yield % too high?
GlobeStar Therapeutics' current FCF Yield % is 0.00.
How does GlobeStar Therapeutics' FCF Yield % compare to GBLX and ENDV?
GlobeStar Therapeutics' FCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on GlobeStar Therapeutics and its competitors. GlobeStar Therapeutics's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlobeStar Therapeutics stock overvalued right now?
GlobeStar Therapeutics (GSTC) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For GlobeStar Therapeutics (GSTC), the current FCF Yield % is 0.00 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlobeStar Therapeutics Business Description

Address 719 Jadewin Avenue, Richland, WA, USA, 99352
GlobeStar Therapeutics Corp is a clinical-stage pharmaceutical company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.